SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 66.79   -6.13 (-8.41%) Volume: 745.86k 4:00 PM EDT 27-Mar-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
10-Q/A[Amend] Quarterly report [Sections 13 or 15(d)]4411/02/2017
4Statement of changes in beneficial ownership of securities110/17/2017
8-KCurrent report pursuant to Section 13 or 15(d)310/10/2017
8-KCurrent report pursuant to Section 13 or 15(d)10010/04/2017
4Statement of changes in beneficial ownership of securities109/06/2017
4Statement of changes in beneficial ownership of securities108/25/2017
3Initial statement of beneficial ownership of securities108/22/2017
4Statement of changes in beneficial ownership of securities108/22/2017
8-KCurrent report pursuant to Section 13 or 15(d)808/21/2017
4Statement of changes in beneficial ownership of securities108/10/2017
4Statement of changes in beneficial ownership of securities108/10/2017
4Statement of changes in beneficial ownership of securities108/10/2017
4Statement of changes in beneficial ownership of securities108/08/2017
10-QGeneral form for quarterly reports under Section 13 or 15(d)11508/09/2017
8-KCurrent report pursuant to Section 13 or 15(d)1408/07/2017
91011121314151617181920212223